ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesJ82.83

J82.83

Eosinophilic asthma

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/06/2025

Code Description

ICD-10 J82.83 is a billable code used to indicate a diagnosis of eosinophilic asthma.

Key Diagnostic Point:

Eosinophilic asthma is a subtype of asthma characterized by elevated levels of eosinophils, a type of white blood cell, in the airways. Clinically, patients may present with symptoms such as wheezing, shortness of breath, chest tightness, and chronic cough, which can vary in severity. The condition is often associated with allergic responses and can be triggered by environmental factors such as pollen, dust mites, and pet dander. Anatomically, eosinophilic asthma primarily affects the bronchial tubes, leading to inflammation, airway hyperresponsiveness, and obstruction. Disease progression can lead to chronic airway remodeling if not adequately managed, resulting in persistent symptoms and reduced lung function. Diagnostic considerations include a thorough patient history, spirometry to assess lung function, and blood tests to measure eosinophil levels. Additionally, bronchoscopy may be utilized to visualize airway inflammation and collect samples for further analysis. Accurate diagnosis is crucial for effective management, which may include inhaled corticosteroids, biologic therapies targeting eosinophils, and bronchodilators.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Diagnostic complexity: Requires specific tests to confirm eosinophilia and differentiate from other asthma types.
  • Treatment complexity: May involve advanced therapies like monoclonal antibodies, requiring careful monitoring.
  • Documentation requirements: Detailed clinical notes are necessary to support the diagnosis and treatment plan.
  • Coding specificity: Requires precise coding to differentiate from other asthma types, impacting reimbursement.

Audit Risk Factors

  • Common coding errors: Misclassification with other asthma types or respiratory conditions.
  • Documentation gaps: Incomplete records regarding eosinophil counts or treatment responses.
  • Billing challenges: Potential denials if documentation does not clearly support the diagnosis.

Specialty Focus

Medical Specialties

Pulmonology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Allergy and Immunology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

Eosinophilic asthma has significant clinical implications, affecting a subset of asthma patients who may experience more severe symptoms and exacerbations. This condition can lead to increased healthcare utilization, including emergency visits and hospitalizations. Understanding its epidemiology is crucial for developing targeted therapies and improving patient outcomes. Quality measures focusing on asthma control and management can help reduce the burden of this condition on the healthcare system.

ICD-9 vs ICD-10

Eosinophilic asthma has significant clinical implications, affecting a subset of asthma patients who may experience more severe symptoms and exacerbations. This condition can lead to increased healthcare utilization, including emergency visits and hospitalizations. Understanding its epidemiology is crucial for developing targeted therapies and improving patient outcomes. Quality measures focusing on asthma control and management can help reduce the burden of this condition on the healthcare system.

Reimbursement & Billing Impact

Eosinophilic asthma has significant clinical implications, affecting a subset of asthma patients who may experience more severe symptoms and exacerbations. This condition can lead to increased healthcare utilization, including emergency visits and hospitalizations. Understanding its epidemiology is crucial for developing targeted therapies and improving patient outcomes. Quality measures focusing on asthma control and management can help reduce the burden of this condition on the healthcare system.

Resources

Clinical References

  • •
    ICD-10 Official Guidelines for J00-J99
  • •
    Clinical Documentation Requirements

Coding & Billing References

  • •
    ICD-10 Official Guidelines for J00-J99
  • •
    Clinical Documentation Requirements

Frequently Asked Questions

What specific conditions are covered by J82.83?

J82.83 specifically covers eosinophilic asthma, which is characterized by elevated eosinophil levels in the blood and airways, leading to asthma symptoms. It is distinct from other asthma types, such as allergic or non-allergic asthma.

When should J82.83 be used instead of related codes?

J82.83 should be used when a patient has confirmed eosinophilic asthma, evidenced by elevated eosinophil counts and asthma symptoms. It should not be used for patients with other asthma types or without eosinophilia.

What documentation supports J82.83?

Documentation should include a detailed patient history, results of eosinophil blood tests, spirometry results, and any treatment plans. Clinical notes should clearly indicate the diagnosis of eosinophilic asthma and the rationale for treatment.